LOGC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LOGC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash Payments for Loans only applicable to companies reporting Cash Flow from Operations in direct method.
Mark J Enyedy | director | C/O FATE THERAPEUTICS, INC., 3535 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO CA 92121 |
Mariana Nacht | officer: Chief Scientific Officer | 65 HAYDEN AVENUE, 2ND FLOOR, LEXINGTON MA 02421 |
Daniel Gruskin | officer: Chief Medical Officer | 65 HAYDEN AVENUE, 2ND FLOOR, LEXINGTON MA 02421 |
Susan Kahn | director | 65 HAYDEN AVENUE, 2ND FLOOR, LEXINGTON MA 02421 |
Joshua Blacher | officer: Interim CFO | 65 HAYDEN AVENUE, 2ND FLOOR, LEXINGTON MA 02421 |
Andrea Paul | officer: General Counsel and Secretary | 65 HAYDEN AVENUE, 2ND FLOOR, LEXINGTON MA 02421 |
Frederic Chereau | director, officer: See Remarks | C/O ATYR PHARMA, INC., 3545 JOHN HOPKINS COURT, SUITE 250, SAN DIEGO CA 92121 |
Kyle Chiang | officer: Chief Operating Officer | 65 HAYDEN AVENUE, 2ND FLOOR, LEXINGTON MA 02421 |
Cecilia Jones | officer: Chief Financial Officer | C/O LOGICBIO THERAPEUTICS, INC., 65 HAYDEN AVENUE, 2ND FLOOR, LEXINGTON MA 02421 |
Jonathan Quick | officer: Senior Director-Finance | C/O LOGICBIO THERAPEUTICS, INC., 65 HAYDEN AVENUE, 2ND FLOOR, LEXINGTON MA 02421 |
Jeff Goater | director | C/O SURFACE ONCOLOGY, INC., 50 HAMPSHIRE STREET, 8TH FLOOR, CAMBRIDGE MA 02139 |
Daphne Karydas | director | 35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3, WALTHAM MA 02451 |
Erez Chimovits | director | P.O. BOX 4023, HERZLIYA PITUACH L3 4614001 |
Orbimed Advisors Llc | director, 10 percent owner | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
Orbimed Genesis Gp Llc | director, 10 percent owner | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.